Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)
NCT02160054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 289
Last updated 2024-10-21
Summary
To evaluate the safety and efficacy of Graceptor ® in patients with kidney transplantation when converted from cyclosporine
Conditions
- the Maintenance Phase After Kidney Transplantation
Interventions
- DRUG
-
Graceptor®
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use Central Contact · Astellas Pharma Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-15
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- Japan
Study Locations
More Related Trials
-
Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients
NCT02555787 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients
NCT00543569 ·Status: COMPLETED ·Phase: PHASE2
-
Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation
NCT02161237 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Prograf® Therapy in Renal Transplant Patients
NCT00297765 ·Status: COMPLETED ·Phase: PHASE4
-
Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation
NCT00903188 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients
NCT00650468 ·Status: COMPLETED ·Phase: PHASE4
-
Optima: Optimizing Prograf Therapy in Maintenance Allografts II
NCT00905515 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
NCT02963103 ·Status: TERMINATED ·Phase: PHASE4
-
Cyclosporine a Pretreatment and Kidney Graft Function
NCT02907554 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
NCT02251691 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants
NCT00257387 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients
NCT01990118 ·Status: COMPLETED ·Phase: PHASE4
-
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
NCT00658359 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
NCT00717678 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients
NCT00617604 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
NCT00204191 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney
NCT00035555 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure
NCT00510913 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Everolimus and Sirolimus in Renal Transplant Recipients
NCT01976390 ·Status: COMPLETED ·Phase: NA
-
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
NCT02974686 ·Status: TERMINATED ·Phase: PHASE4
-
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
NCT02581436 ·Status: COMPLETED ·Phase: NA
-
Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation
NCT01002339 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients
NCT01064791 ·Status: COMPLETED ·Phase: PHASE2
-
Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation
NCT00123331 ·Status: COMPLETED ·Phase: PHASE4
-
OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
NCT02005562 ·Status: COMPLETED ·Phase: PHASE3